字号·· | 护眼
卫报

印度在法院裁定药品加价属于“敲诈”后降低抗癌药物价格India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’

点「原文对照」整页切到原文,或双击某段只看那段的原文。

从下个月起,受印度最高法院裁决推动,137种抗癌药物的价格预计将下降高达70%。 摄影:Rupendra Rawat/AlamyFrom next month, prodded by the findings of India’s supreme court, prices of 137 cancer drugs are expected to fall by up to 70%. Photograph: Rupendra Rawat/Alamy

2022年,一名患者因无法负担药品费用而提起诉讼,这一案件促使政府对抗癌药物价格实施上限规定。如今,数百万患者因此受益。

Case filed in 2022 by patient unable to afford medicine leads to cap on drug prices for millions who face ruin if diagnosed The Indian government has moved to reduce the price of cancer drugs after a retired bank clerk took her case to the supreme court.

因无力支付抗癌药物费用,Sarojam Radhakrishan发起了诉讼。 摄影:FacebookSarojam Radhakrishan initiated the court action after being unable to pay for her cancer drugs. Photograph: Facebook

在一位退休银行职员将此事诉至最高法院后,印度政府采取了这一措施。从下个月起,印度将有137种抗癌药物的价格下调。

政府此举旨在解决贫困患者因药品高昂费用而放弃治疗、卖掉土地或负债的问题,这些药品为医院和药商带来了巨额利润。

From next month, 137 cancer drugs in India will be cheaper as the government tries to tackle the tragedy of poorer patients either forgoing treatment, selling land or falling into debt to meet the high cost of some medicines, which are making large profits for hospitals and pharmacists.

新德里最高法院,法官们要求政府解释为何价格上限仅适用于抗癌药物,而不适用于所有非专利药物。 摄影:APThe supreme court in New Delhi, where judges have asked the government to explain why the price cap should apply only to cancer drugs and not all non-patented drugs Photograph: AP
阅读媒体原文 ↗